| pubmed-article:7568827 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7568827 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
| pubmed-article:7568827 | lifeskim:mentions | umls-concept:C0006118 | lld:lifeskim |
| pubmed-article:7568827 | lifeskim:mentions | umls-concept:C0597295 | lld:lifeskim |
| pubmed-article:7568827 | lifeskim:mentions | umls-concept:C0041485 | lld:lifeskim |
| pubmed-article:7568827 | lifeskim:mentions | umls-concept:C0175631 | lld:lifeskim |
| pubmed-article:7568827 | lifeskim:mentions | umls-concept:C2827662 | lld:lifeskim |
| pubmed-article:7568827 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:7568827 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
| pubmed-article:7568827 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:7568827 | pubmed:dateCreated | 1995-11-1 | lld:pubmed |
| pubmed-article:7568827 | pubmed:abstractText | Positron emission tomography (PET) with the amino acid tracer L-[1-C-11]-tyrosine was evaluated in 27 patients with primary and recurrent brain tumors. | lld:pubmed |
| pubmed-article:7568827 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7568827 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7568827 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7568827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7568827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7568827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7568827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7568827 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7568827 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:7568827 | pubmed:issn | 0033-8419 | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:GoK GKG | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:VaalburgWW | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:PabloC LCL | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:MolenaarW MWM | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:van WaardeAA | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:VisserG MGM | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:PruimJJ | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:FranssenE JEJ | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:WillemsenA... | lld:pubmed |
| pubmed-article:7568827 | pubmed:author | pubmed-author:HeestersM AMA | lld:pubmed |
| pubmed-article:7568827 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7568827 | pubmed:volume | 197 | lld:pubmed |
| pubmed-article:7568827 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7568827 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7568827 | pubmed:pagination | 221-6 | lld:pubmed |
| pubmed-article:7568827 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:meshHeading | pubmed-meshheading:7568827-... | lld:pubmed |
| pubmed-article:7568827 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7568827 | pubmed:articleTitle | Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate. | lld:pubmed |
| pubmed-article:7568827 | pubmed:affiliation | National Research Positron Emission Tomography (PET) Center, Groningen, The Netherlands. | lld:pubmed |
| pubmed-article:7568827 | pubmed:publicationType | Journal Article | lld:pubmed |
